functions and tissue repair capacities, which have facilitated the clinical applications of MSCs in treating a diverse range of disorders involving angiogenesis and fibrosis, including rheumatic diseases and graft-versus-host diseases. 2, 3 Here, we provide a brief commentary on newly emerging evidence of the immunoregulatory function and potential application of ecto-mesenchymal stem cells.
IMMUNOREGULATORY FUNCTIONS OF ECTO-MESENCHYMAL STEM CELLS
Recent studies have identified a novel MSC subset in nasal lamina propria, namely, olfactory ecto-mesenchymal stem cells (OE-MSCs). 4, 5 OE-MSCs can differentiate, similar to MSCs derived from other tissues or organs, yet OEMSCs also display neurogenic capacity. Upon transplantation into mice with hippocampal lesions, human OE-MSCs can stimulate endogenous neurogenesis and promote synaptic transmission. 6 Remarkably, OE-MSC-treated mice exhibit improved learning and memory capabilities in behavioral tests. 6 Although both the tissue repair and regeneration capacity of OE-MSCs have been well studied, whether OE-MSCs also possess immunomodulatory function has remained largely unclear. Recently, we have characterized the functional features of OE-MSCs both in vitro and in vivo. 7 Previous studies have suggested that immunoregulatory factors produced by MSCs, such as nitric oxide (NO), indoleamine 2,3-dioxygenase (IDO), programmed death-1 ligand (PD-L1) and interleukin-10 (IL-10), contribute to the formation of an immunosuppressive milieu. 8 Consistent with these observations, we detected significantly higher PD-L1 expression and a stronger capacity of OE-MSCs to produce NO, IL-10 and TGF-β when compared with BM-derived MSCs (BM-MSCs). 7 Altogether, these findings demonstrate the immunoregulatory function of OEMSCs. Our recent studies have shown that umbilical cord-derived MSC transplantation increases Treg cells and reduces Th17 cells through the regulation of TGF-β and PGE2 in lupus patients. 9, 10 This evidence supports the potential application of OE-MSCs in the treatment of autoimmune diseases and other disorders with immune dysregulations.
FUNCTIONAL MODULATIONS OF ECTO-MESENCHYMAL STEM CELLS
Accumulated data have suggested that inflammatory stimuli from a tissue's microenvironment can reciprocally affect the functionality and plasticity of MSCs under conditions of infection, autoimmunity and cancer. 8 There is also evidence indicating that immunosuppressive functions are not constitutively possessed by MSCs. Instead, local inflammatory factors may license MSCs to become immunosuppressive. 11 Among many inflammatory cytokines and chemokines, IFN-γ is found to be essentially involved in eliciting the immunosuppressive functions of MSCs. 12, 13 Elegant studies by Ren et al. 14 have further demonstrated that the concomitant presence of other proinflammatory cytokines (TNF-α, IL-1α or IL-β) with IFN-γ are required to induce immunosuppression by MSCs through the concerted action of chemokines and NO. IL-17 has been identified as a key proinflammatory cytokine in the pathogenesis of various autoimmune diseases. Interestingly, Han et al. 15 18 As a novel MSC subset, OE-MSCs are broadly distributed within the lamina propria of the superior, middle and inferior turbinates in the nasal cavity. Thus, OE-MSCs are easily accessible for sample harvest and can be rapidly expanded in culture. 19 Current studies indicate that OE-MSC engraftment is well tolerated and highly competent with immunomodulatory functions for treating neural tissue injuries and autoimmune arthritis in animal models. Despite their similar or even identical phenotypes, MSCs derived from different tissues have been shown to elicit variable therapeutic effects owing to their unique genetic signatures, migratory capacities, isolation methods and passage times upon adoptive transfer. 20, 21 Although rapid advances have been achieved in utilizing MSCs as an effective cellular therapy in clinical applications, several studies have reported that MSCbased therapies fail to reach the primary endpoints. 22, 23 Thus, further investigations are needed to unveil the mechanistic network that functionally shapes MSC activities and to optimize the clinical protocol of MSC therapy for future treatment, which will contribute to the validation of OE-MSCs as a new candidate for cell therapy. 24 
